Do Urate Targets Influence CV Risk? - Top-Institutions - MDSpire

Do Urate Targets Influence CV Risk?

Researchers examine whether achieving treat-to-target serum urate levels with urate-lowering treatment affects long-term cardiovascular outcomes in patients with gout.

  • By

  • Kathryn Wighton

  • January 30, 2026

  • 3 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    University of Oxford
    University of Oxford

    Oxford, Oxfordshire

    Key Differentiators

    • Rheumatology
    • Cardiovascular Epidemiology
    • Clinical Pharmacology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Rheumatology
    • Cardiology
    • Clinical Research

  • #3

    Brigham and Women’s Hospital / Harvard Medical School
    Brigham and Women’s Hospital / Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Rheumatology
    • Cardiology
    • Epidemiology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, California

    Key Differentiators

    • Rheumatology
    • Cardiology
    • Clinical Epidemiology

Original Source(s)

Do Urate Targets Influence CV Risk?

  • by Kathryn Wighton

  • January 30, 2026

Related Content

Clinical Decision Support System, Antihypertensive Treatment Intensification, and Blood Pressure Control: A

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.